Clinical Trial Update: Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing metformin XR monotherapy to metformin IR monotherapy in adults with Type 2 diabetes completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin IR (metformin)
• metformin XR (metformin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2017-07-21